These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8161607)

  • 1. Conformational study of cyclo[Gln-Trp-Phe-Gly-Leu-Met] as NK-2 antagonist by NMR and molecular dynamics.
    Siahaan TJ; Lutz K
    J Pharm Biomed Anal; 1994 Jan; 12(1):65-71. PubMed ID: 8161607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution conformation of a cyclic neurokinin antagonist: a NMR and molecular dynamics study.
    Zhang M; Quinn TP; Wong TC
    Biopolymers; 1994 Sep; 34(9):1165-73. PubMed ID: 7948730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution conformation of c-[Gln-Trp-Phe-Gly-Leu-Met], a NK-2 tachykinin antagonist.
    Amodeo P; Rovero P; Saviano G; Temussi PA
    Int J Pept Protein Res; 1994 Dec; 44(6):556-61. PubMed ID: 7705977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic peptides as selective tachykinin antagonists.
    Williams BJ; Curtis NR; McKnight AT; Maguire JJ; Young SC; Veber DF; Baker R
    J Med Chem; 1993 Jan; 36(1):2-10. PubMed ID: 7678430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEN 10,627, a novel polycyclic peptide antagonist of tachykinin NK2 receptors.
    Maggi CA; Astolfi M; Giuliani S; Goso C; Manzini S; Meini S; Patacchini R; Pavone V; Pedone C; Quartara L
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1489-500. PubMed ID: 7996462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H][beta-Ala8]neurokinin A-(4-10): a novel, selective radioligand for the tachykinin NK2 receptor.
    Goso C; Astolfi M; Parlani M; Manzini S
    Eur J Pharmacol; 1995 Dec; 294(1):239-45. PubMed ID: 8788437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative conformational analysis and in vitro pharmacological evaluation of three cyclic hexapeptide NK-2 antagonists.
    Wollborn U; Brunne RM; Harting J; Hölzemann G; Leibfritz D
    Int J Pept Protein Res; 1993 Apr; 41(4):376-84. PubMed ID: 8388367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity study of neurokinins: antagonists for the neurokinin-2 receptor.
    Dion S; Rouissi N; Nantel F; Jukic D; Rhaleb NE; Tousignant C; Télémaque S; Drapeau G; Regoli D; Naline E
    Pharmacology; 1990; 41(4):184-94. PubMed ID: 1964226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic hexapeptide NK-2 antagonists.
    Hölzemann G; Löw A; Harting J; Greiner HE
    Int J Pept Protein Res; 1994 Aug; 44(2):105-11. PubMed ID: 7527014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of aromatic residues in transmembrane segments V to VII for binding of peptide and nonpeptide antagonists to the human tachykinin NK(2) receptor.
    Renzetti AR; Catalioto RM; Criscuoli M; Cucchi P; Ferrer C; Giolitti A; Guelfi M; Rotondaro L; Warner FJ; Maggi CA
    J Pharmacol Exp Ther; 1999 Aug; 290(2):487-95. PubMed ID: 10411554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined use of molecular dynamics simulations and NMR to explore peptide bond isomerization and multiple intramolecular hydrogen-bonding possibilities in a cyclic pentapeptide, cyclo(Gly-Pro-D-Phe-Gly-Val).
    Liu ZP; Gierasch LM
    Biopolymers; 1992 Dec; 32(12):1727-39. PubMed ID: 1472655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different mechanism of tachykinin NK2 receptor blockade by SR 48968 and MEN 10,627 in the guinea-pig isolated gallbladder and colon.
    Patacchini R; De Giorgio R; Giachetti A; Maggi CA
    Eur J Pharmacol; 1994 Dec; 271(1):111-9. PubMed ID: 7698194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformation of a neurokinin antagonist in solution. 2D NMR and restrained molecular dynamics study.
    Malikayil JA; Harbeson SL
    Int J Pept Protein Res; 1992 Jun; 39(6):497-505. PubMed ID: 1328098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic cholecystokinin-analog pentapeptide cyclo (Asp-Trp-Met-Asp-Phe): an unexpected solution conformation.
    Weisshoff H; Wieprecht T; Henklein P; Antz C; Mügge C
    Biochem Biophys Res Commun; 1995 Aug; 213(2):506-12. PubMed ID: 7646505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative conformational studies on cyclic hexapeptides corresponding to message sequence His-Phe-Arg-Trp of alpha-melanotropin by NMR.
    Prachand MS; Dhingra MM; Saran A; Coutinho E; Bodi J; Süli-Vargha H; Medzihardszky K
    J Pept Res; 1998 Apr; 51(4):251-65. PubMed ID: 9560000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nepadutant at tachykinin NK(2) receptors in human intestine and urinary bladder.
    Patacchini R; Giuliani S; Turini A; Navarra G; Maggi CA
    Eur J Pharmacol; 2000 Jun; 398(3):389-97. PubMed ID: 10862829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure determination and by-product profile of the NK(2) receptor antagonist nepadutant, a bicyclic glycopeptide.
    Weisshoff H; Nagel T; Hänsicke A; Zschunke A; Mügge C
    FEBS Lett; 2001 Mar; 491(3):299-304. PubMed ID: 11240145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational analysis of cyclic peptides in solution.
    Kessler H; Bats JW; Wagner K; Will M
    Biopolymers; 1989 Jan; 28(1):385-95. PubMed ID: 2720115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational study of cyclo[D-Trp-D-Asp-Pro-D-Val-Leu], an endothelin-A receptor-selective antagonist.
    Atkinson RA; Pelton JT
    FEBS Lett; 1992 Jan; 296(1):1-6. PubMed ID: 1309703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the antibronchoconstrictor activity of MEN 11420, a tachykinin NK2 receptor antagonist, in guinea-pigs.
    Tramontana M; Patacchini R; Giuliani S; Lippi A; Lecci A; Santicioli P; Criscuoli M; Maggi CA
    Eur J Pharmacol; 1998 Jul; 352(2-3):279-88. PubMed ID: 9716365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.